A unique shareholding structure
Pierre Fabre Laboratories is based on a unique shareholding structure, in accordance with the wishes of its founder to ensure stability and independence: the government recognized public-interest Foundation and our employees are the only shareholders.
Pierre Fabre Laboratories is based on a unique shareholding structure, in accordance with the wishes of its founder to ensure stability and independence: the government recognized public-interest Foundation and our employees are the only shareholders. This atypical capital structure preserves our independence and focuses on the long term, for the benefit of patients, consumers, employees and stakeholders. And, by its very nature, it ensures that we remain a mission based company, because the dividends paid fund the humanitarian projects of a government-recognized public-interest fondation.
The Foundation, our majority shareholder
Recognized as a French “public interest” organization, the Pierre Fabre Foundation holds 86% of shares of Pierre Fabre SA. It strives to carry out its mission every day: enable populations of the Global South to have better access to quality drugs and health care. The Foundation delegates Group management control to Pierre Fabre Participations, which nominates the main company leaders while ensuring that its founder’s humanist values are observed.
Employees, co-owners of the company
Our employees are the Group’s second largest shareholders: they hold 9.2% of the capital. The Ruscus employee stock ownership plan involves them in the company’s development, allowing them to benefit from the fruits of our growth. Initially deployed in France in 2005, it has since been extended to 13 countries. In 2022, 85% of employees eligible for subscription were shareholders. This level of support is a demonstration of their confidence in their Group’s strategy and its success. And our employees want to preserve this singular model, which allows fair distribution of the value created from everyone’s work.